ATE392419T1 - Androgenmodulatoren - Google Patents
AndrogenmodulatorenInfo
- Publication number
- ATE392419T1 ATE392419T1 AT05779469T AT05779469T ATE392419T1 AT E392419 T1 ATE392419 T1 AT E392419T1 AT 05779469 T AT05779469 T AT 05779469T AT 05779469 T AT05779469 T AT 05779469T AT E392419 T1 ATE392419 T1 AT E392419T1
- Authority
- AT
- Austria
- Prior art keywords
- directed
- androgen modulators
- modulators
- androgen
- benzonitriles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Cosmetics (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60589604P | 2004-08-31 | 2004-08-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE392419T1 true ATE392419T1 (de) | 2008-05-15 |
Family
ID=35453498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05779469T ATE392419T1 (de) | 2004-08-31 | 2005-08-22 | Androgenmodulatoren |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20070207987A1 (de) |
| EP (1) | EP1789408B1 (de) |
| JP (1) | JP2008511606A (de) |
| KR (1) | KR20070049238A (de) |
| CN (1) | CN101044131A (de) |
| AT (1) | ATE392419T1 (de) |
| AU (1) | AU2005278892A1 (de) |
| BR (1) | BRPI0514706A (de) |
| CA (1) | CA2578194A1 (de) |
| DE (1) | DE602005006139T2 (de) |
| ES (1) | ES2302229T3 (de) |
| IL (1) | IL181447A0 (de) |
| MX (1) | MX2007002377A (de) |
| NO (1) | NO20070953L (de) |
| WO (1) | WO2006024942A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007533726A (ja) | 2004-04-22 | 2007-11-22 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | アンドロゲンモジュレーター |
| MXPA06015169A (es) | 2004-07-08 | 2007-08-21 | Warner Lambert Co | Moduladores de androgenos. |
| TW200724139A (en) | 2005-05-05 | 2007-07-01 | Warner Lambert Co | Androgen modulators |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3164523A (en) * | 1961-03-22 | 1965-01-05 | Warner Lambert Pharmaceutical | Composition for skin beautification and treatment |
| DE10218963A1 (de) * | 2002-04-27 | 2003-11-20 | Aventis Pharma Gmbh | Zubereitungen zur topischen Applikation von antiandrogen wirksamen Substanzen |
| JP2007521328A (ja) * | 2003-11-20 | 2007-08-02 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | アンドロゲン受容体モジュレーター |
| CA2554696C (en) * | 2004-02-13 | 2009-06-30 | Warner-Lambert Company Llc | Androgen receptor modulators |
| US7507860B2 (en) * | 2004-04-13 | 2009-03-24 | Pfizer Inc. | Androgen modulators |
| JP2007533726A (ja) * | 2004-04-22 | 2007-11-22 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | アンドロゲンモジュレーター |
-
2005
- 2005-08-22 KR KR1020077007406A patent/KR20070049238A/ko not_active Application Discontinuation
- 2005-08-22 ES ES05779469T patent/ES2302229T3/es active Active
- 2005-08-22 EP EP05779469A patent/EP1789408B1/de not_active Not-in-force
- 2005-08-22 CA CA002578194A patent/CA2578194A1/en not_active Abandoned
- 2005-08-22 US US11/572,748 patent/US20070207987A1/en not_active Abandoned
- 2005-08-22 BR BRPI0514706-9A patent/BRPI0514706A/pt not_active Application Discontinuation
- 2005-08-22 JP JP2007529030A patent/JP2008511606A/ja not_active Withdrawn
- 2005-08-22 CN CNA2005800355173A patent/CN101044131A/zh active Pending
- 2005-08-22 AU AU2005278892A patent/AU2005278892A1/en not_active Abandoned
- 2005-08-22 WO PCT/IB2005/002700 patent/WO2006024942A1/en active IP Right Grant
- 2005-08-22 AT AT05779469T patent/ATE392419T1/de active
- 2005-08-22 DE DE602005006139T patent/DE602005006139T2/de active Active
- 2005-08-22 MX MX2007002377A patent/MX2007002377A/es unknown
-
2007
- 2007-02-20 IL IL181447A patent/IL181447A0/en unknown
- 2007-02-20 NO NO20070953A patent/NO20070953L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20070207987A1 (en) | 2007-09-06 |
| BRPI0514706A (pt) | 2008-06-24 |
| EP1789408A1 (de) | 2007-05-30 |
| IL181447A0 (en) | 2007-07-04 |
| KR20070049238A (ko) | 2007-05-10 |
| DE602005006139T2 (de) | 2009-05-07 |
| DE602005006139D1 (de) | 2008-05-29 |
| JP2008511606A (ja) | 2008-04-17 |
| MX2007002377A (es) | 2007-04-23 |
| AU2005278892A1 (en) | 2006-03-09 |
| CA2578194A1 (en) | 2006-03-09 |
| CN101044131A (zh) | 2007-09-26 |
| ES2302229T3 (es) | 2008-07-01 |
| EP1789408B1 (de) | 2008-04-16 |
| WO2006024942A1 (en) | 2006-03-09 |
| NO20070953L (no) | 2007-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200605876A (en) | Androgen modulators | |
| MX2007001993A (es) | Moduladores de androgenos. | |
| TW200724139A (en) | Androgen modulators | |
| NO20063064L (no) | Ny anvendelse av peptidforbindelser for behandling av sentralneurotisk smerte | |
| EA200602221A1 (ru) | Новое применение пептидных соединений для лечения боли при тригеминальной невралгии | |
| EA200700702A1 (ru) | Аналоги локсапина и способы их применения | |
| EA200601267A1 (ru) | Модуляторы рецепторов андрогена | |
| WO2007017754A3 (en) | Androgen modulators | |
| BRPI0510177B8 (pt) | composto, composição farmacêutica e uso do mesmo | |
| BRPI0509759A (pt) | moduladores de androgênio | |
| IS8913A (is) | Afleiður 4-tetrazólýl-4-fenýlpiperidíns til þess að meðhöndla verk | |
| GEP20094844B (en) | 3-aminocyclopentane carboxamides as modulators of chemokine receptors | |
| EA200700934A1 (ru) | Производные пиримидина и их применение в качестве модуляторов cb2 | |
| GEP20094843B (en) | 3-aminocyclopentane carboxamides as modulators of chemokine receptors | |
| CR9652A (es) | Moduladores de alquilquinolina y alquilquinazolina cinasa | |
| EA200971141A1 (ru) | Соединения, активирующие теломеразу, и способы их применения | |
| CA2562672A1 (en) | 4-cyano-phenoxy derivatives as androgen modulators | |
| SE0401465D0 (sv) | New substituted piperdines as modulators of dopamine neurotransmission | |
| NO20070953L (no) | Androgenmodulatorer | |
| BR0316132A (pt) | Método para estimular o crescimento de cabelo utilizando benzopiranos | |
| DE50308460D1 (de) | Verwendung von ambroxol zur behandlung von chronischen schmerzen | |
| EA200801407A1 (ru) | Модуляторы эстрогена | |
| RS52038B (en) | USE OF 7-BUTOXYIMINOMETHYLAMPTOTECIN FOR THE TREATMENT OF NON-PLASMA NEOPLASMS | |
| DOP2005000129A (es) | Moduladores de androgenos | |
| MX2007010374A (es) | Inhibidor de acat cristalino. |